RxDoctor Payments Data

Elizabeth Dowling

Psychiatric/Mental Health, Adult · Plymouth Meeting, PANPI 1518167501

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $687, more than ten times the $18 reported in 2023.

$1,354in general payments, 2019–2025

Across 77 payments — averaging $17.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$276
  • AbbVie$228
  • Lundbeck LLC$159
  • Takeda Pharmaceuticals U.S.A., Inc.$145
  • Vanda Pharmaceuticals Inc.$141
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$78
  • plus $329 from 8 others

What the payments were for

  • Food & beverage$1,354100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,354 in reported general payments places this provider in the 70th percentile of 20 psychiatric/mental health, adult providers in Pennsylvania.

See all psychiatric/mental health, adult providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$13,199
Medicare patients
37
Services billed
108

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Aripiprazole11$2,380
Bupropion XlBupropion Hcl46$1,185
Trazodone Hcl46$578
Fluoxetine Hcl31$460
Buspirone Hcl21$456
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine15$420
Quetiapine Fumarate27$387
Duloxetine Hcl17$383
Lamotrigine36$334
Escitalopram Oxalate20$248
Clonazepam44$223
Risperidone20$209
Sertraline Hcl44$141
Lorazepam36$136
Zolpidem Tartrate12$89

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health, adult in Plymouth Meeting

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →